Viral Weight Loss Drugs BACKFIRE

I’ve been tracking the saga of the latest weight loss drugs for a few years now.

Not because of their incredible weight-loss results… but because their reported side effects are allegedly ruining some people’s lives.

At first, the shocking side effects were anecdotal—and most doctors don’t give a hill of beans about an individual person’s experience. But with hundreds of thousands now taking these drugs for weight loss, I KNEW that would soon change.

Well, now we have something better… THREE new studies confirm the elevated risk for an extreme side effect of these drugs that some folks have been warning about for years.

GPL-1s are injectable weight-loss drugs that stimulate the GLP-1 receptor. One way these drugs work is by slowing the movement of food through the stomach.

Called delayed gastric emptying, this can help you feel full after eating less food, which naturally can contribute to weight loss.

Delayed gastric emptying can trigger gastroparesis or paralysis of the stomach. This can lead to issues like a feeling of fullness, bloating, vomiting, abdominal pain, and nausea.

In severe cases, it causes dehydration and malnutrition.

Plenty of anecdotal evidence has shown this risk, and now several studies have confirmed it.

One study evaluated records of more than 286,000 people who were overweight but didn’t have type 2 diabetes who were taking a GLP-1 medication.

Results showed that people taking GLP-1 drugs had a 52 percent greater risk of gastroparesis compared to people not taking the meds.

The second study examined records of more than 300,000 people, including type 2 diabetics, taking these weight-loss meds.

These results were even MORE alarming, showing that people taking the drugs were 62 percent more likely to be diagnosed with gastroparesis compared to those not taking the drug.

Those taking the drugs also had a higher risk of nausea, vomiting, gastrointestinal reflux, gallbladder removal, and drug-induced pancreatitis.

The worst part? None of this is surprising.

That’s because in the clinical trials of Wegovy in particular, 44 percent of patients had nausea, 24 percent experienced vomiting, and 20 percent had abdominal pain.

The Wegovy package insert even warns of possible side effects, including acute pancreatitis, hypoglycemia, gallbladder disease, allergic reactions, diabetic retinopathy complications, and suicidal behavior and ideation.

This is one situation where I hate to say, I told you so.

I sounded the alarm about this years ago, but my voice got drowned out in the frenzy over a quick-fix for weight loss.

If you’re a subscriber to my Natural Health Response newsletter, see the December 2023 issue for more on this topic. Not a subscriber yet? No problem. CLICK HERE to get the details on how to join us.

I’m not saying that losing weight is easy, but it’s clear that these risky drugs are NOT the solution.

P.S. “Window” weight loss trick SLASHES diabetes risk (and More!)

SOURCE:

Digestive Disease Week 2024, Washington, DC, May 18-21, 2024, [ddw.org/]